• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常受试者和心力衰竭患者中B型利钠肽与A型利钠肽分泌的定位及机制比较

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

作者信息

Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K

机构信息

Division of Cardiology, Kumamoto University School of Medicine, Japan.

出版信息

Circulation. 1994 Jul;90(1):195-203. doi: 10.1161/01.cir.90.1.195.

DOI:10.1161/01.cir.90.1.195
PMID:8025996
Abstract

BACKGROUND

B-type or brain natriuretic peptide (BNP) is a novel natriuretic peptide secreted from the heart that forms a peptide family with A-type or atrial natriuretic peptide (ANP), and its plasma level has been shown to be increased in patients with congestive heart failure. This study was designed to examine the sources and mechanisms of the secretion of BNP in comparison with those of ANP in control subjects and in patients with heart failure.

METHODS AND RESULTS

We measured the plasma levels of BNP as well as ANP in 16 patients with dilated cardiomyopathy (11 men and 5 women; mean age, 59 years) and 18 control subjects (9 men and 9 women; mean age, 54 years) by sampling blood from the femoral vein, the aortic root, the anterior interventricular vein (AIV), and the coronary sinus using the newly developed immunoradiometric assay systems. In the control subjects, there was no significant difference in the plasma ANP level between the aortic root and the AIV (24.0 +/- 5.2 pg/mL versus 32.2 +/- 17.0 pg/mL), but there was a highly significant step-up of the level between the AIV and the coronary sinus (32.2 +/- 17.0 pg/mL versus 371.4 +/- 111.1 pg/mL, P < .001). In contrast, there was a significant step-up of the plasma BNP level between the aortic root and the AIV (8.6 +/- 6.4 pg/mL versus 19.0 +/- 11.5 pg/mL, P < .01) but not between the AIV and the coronary sinus (19.0 +/- 11.5 pg/mL versus 28.8 +/- 14.0 pg/mL). On the other hand, in patients with dilated cardiomyopathy, there was a significant step-up in the plasma ANP level between the aortic root and the AIV (280.6 +/- 183.7 pg/mL versus 612.3 +/- 431.6 pg/mL, P < .01) and between the AIV and the coronary sinus (612.3 +/- 431.6 pg/mL versus 1229.0 +/- 772.7 pg/mL, P < .01). There was a significant step-up in the plasma BNP level between the aortic root and the AIV (268.4 +/- 293.2 pg/mL versus 511.6 +/- 458.1 pg/mL, P < .01) but not between the AIV and the coronary sinus (511.6 +/- 458.1 pg/mL versus 529.7 +/- 455.3 pg/mL) in patients with dilated cardiomyopathy. The arteriovenous difference at the AIV of the plasma level of BNP had a significant positive correlation with left ventricular end-systolic volume index (r = 0.859, P < .001) and a significant negative correlation with left ventricular ejection fraction (r = -.735, P < .001).

CONCLUSIONS

We conclude that (1) BNP is secreted mainly from the left ventricle in normal adult humans as well as in patients with left ventricular dysfunction, whereas ANP is secreted from atria in normal adult humans and also from the left ventricle in patients with left ventricular dysfunction; (2) secretion of BNP as well as ANP from the left ventricle increases in proportion to the severity of the left ventricular dysfunction, suggesting that the secretions of ANP and BNP from the left ventricle are regulated mainly by wall tension of the left ventricle; and (3) the peripheral plasma levels of ANP and BNP reflect the secretion rate of these hormones from the left ventricle and may be used as a marker of the degree of left ventricular dysfunction in patients with left ventricular dysfunction.

摘要

背景

B型或脑钠肽(BNP)是一种从心脏分泌的新型利钠肽,它与A型或心房利钠肽(ANP)构成一个肽家族,并且充血性心力衰竭患者的血浆水平已被证明会升高。本研究旨在比较对照组和心力衰竭患者中BNP与ANP的分泌来源和机制。

方法与结果

我们使用新开发的免疫放射分析系统,从股静脉、主动脉根部、前室间静脉(AIV)和冠状窦采集血液,测量了16例扩张型心肌病患者(11例男性和5例女性;平均年龄59岁)和18例对照者(9例男性和9例女性;平均年龄54岁)的血浆BNP以及ANP水平。在对照者中,主动脉根部和AIV之间的血浆ANP水平无显著差异(24.0±5.2 pg/mL对32.2±17.0 pg/mL),但AIV和冠状窦之间的水平有高度显著升高(32.2±17.0 pg/mL对371.4±111.1 pg/mL,P<.001)。相比之下,主动脉根部和AIV之间的血浆BNP水平有显著升高(8.6±6.4 pg/mL对19.0±11.5 pg/mL,P<.01),但AIV和冠状窦之间无显著升高(19.0±11.5 pg/mL对28.8±14.0 pg/mL)。另一方面,在扩张型心肌病患者中,主动脉根部和AIV之间的血浆ANP水平有显著升高(280.6±183.7 pg/mL对612.3±431.6 pg/mL,P<.01),AIV和冠状窦之间也有显著升高(612.3±431.6 pg/mL对1229.0±772.7 pg/mL,P<.01)。扩张型心肌病患者中,主动脉根部和AIV之间的血浆BNP水平有显著升高(268.4±293.2 pg/mL对511.6±458.1 pg/mL,P<.01),但AIV和冠状窦之间无显著升高(511.6±458.1 pg/mL对529.7±455.3 pg/mL)。AIV处血浆BNP水平的动静脉差值与左心室收缩末期容积指数呈显著正相关(r = 0.859,P<.001),与左心室射血分数呈显著负相关(r = -.735,P<.001)。

结论

我们得出结论:(1)正常成年人以及左心室功能障碍患者中,BNP主要从左心室分泌,而正常成年人中ANP从心房分泌,左心室功能障碍患者中ANP也从左心室分泌;(2)左心室中BNP和ANP的分泌与左心室功能障碍的严重程度成比例增加,这表明左心室中ANP和BNP的分泌主要受左心室壁张力调节;(3)外周血浆中ANP和BNP水平反映了这些激素从左心室的分泌速率,可作为左心室功能障碍患者左心室功能障碍程度的标志物。

相似文献

1
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.正常受试者和心力衰竭患者中B型利钠肽与A型利钠肽分泌的定位及机制比较
Circulation. 1994 Jul;90(1):195-203. doi: 10.1161/01.cir.90.1.195.
2
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.充血性心力衰竭患者心房利钠肽和脑利钠肽的不同分泌模式。
Circulation. 1993 Feb;87(2):464-9. doi: 10.1161/01.cir.87.2.464.
3
Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction.运动对伴或不伴左心室功能障碍的充血性心力衰竭患者血浆脑钠肽水平的影响。
Am Heart J. 1995 Jan;129(1):139-45. doi: 10.1016/0002-8703(95)90054-3.
4
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.脑钠肽作为一种新型的人体心脏激素。存在精密的双重利钠肽系统——心房利钠肽和脑钠肽的证据。
J Clin Invest. 1991 Apr;87(4):1402-12. doi: 10.1172/JCI115146.
5
Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.血浆脑钠肽和心房钠尿肽浓度与左心室舒张末期压力相关。
Clin Cardiol. 1993 Jul;16(7):553-7. doi: 10.1002/clc.4960160708.
6
[Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].地高辛对慢性充血性心力衰竭患者心房利钠肽(ANP)、脑利钠肽(BNP)及环磷酸鸟苷(cGMP)的影响
Pol Arch Med Wewn. 2001 Jun;105(6):475-82.
7
Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction.陈旧性心肌梗死患者中 A 型和 B 型利钠肽分泌模式的比较。
J Am Coll Cardiol. 1995 Apr;25(5):1105-10. doi: 10.1016/0735-1097(94)00525-u.
8
Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure.心力衰竭患者中 A 型和 B 型利钠肽之间的代谢清除相互作用。
Metabolism. 2000 Sep;49(9):1228-33. doi: 10.1053/meta.2000.8602.
9
Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.扩张型心肌病患者左心室心房利钠多肽分泌增加。
J Clin Invest. 1989 Jan;83(1):46-51. doi: 10.1172/JCI113883.
10
Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide.人脑利钠肽的生物合成、分泌及受体选择性
Can J Physiol Pharmacol. 1991 Oct;69(10):1500-6. doi: 10.1139/y91-225.

引用本文的文献

1
Prognostic Implications of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide Dynamics in Patients Undergoing Cardiac Surgery.心脏手术患者术前N端前体B型利钠肽动态变化的预后意义
JACC Adv. 2025 Aug 26;4(9):102096. doi: 10.1016/j.jacadv.2025.102096.
2
Cardiovascular Risk and Its Presentation in Chronic Kidney Disease.心血管风险及其在慢性肾脏病中的表现
J Clin Med. 2025 Jun 27;14(13):4567. doi: 10.3390/jcm14134567.
3
Prognostic value of NT-proANP levels on major cardiovascular outcomes in a 31-year follow-up study depends on baseline morbidity.
在一项31年的随访研究中,NT-proANP水平对主要心血管结局的预后价值取决于基线发病率。
Sci Rep. 2025 May 28;15(1):18660. doi: 10.1038/s41598-025-03819-6.
4
Early Changes in Left Ventricular Myocardial Mechanics After Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis.重度主动脉瓣狭窄经导管主动脉瓣置换术后左心室心肌力学的早期变化
Circ Rep. 2025 Mar 27;7(5):365-371. doi: 10.1253/circrep.CR-24-0139. eCollection 2025 May 9.
5
Current Prognostic Biomarkers for Peripheral Arterial Disease: A Comprehensive Systematic Review of the Literature.外周动脉疾病的当前预后生物标志物:文献的全面系统综述
Metabolites. 2025 Mar 25;15(4):224. doi: 10.3390/metabo15040224.
6
Effect of heart rate on B-type natriuretic peptide in sinus rhythm.心率对窦性心律下B型利钠肽的影响。
Sci Rep. 2024 Dec 30;14(1):31711. doi: 10.1038/s41598-024-81922-w.
7
Proteomics in Acute Heart Transplant Rejection, on Behalf of the GRAfT Investigators.代表移植研究组的急性心脏移植排斥反应中的蛋白质组学
Transplantation. 2025 Jul 1;109(7):1230-1240. doi: 10.1097/TP.0000000000005258. Epub 2024 Dec 3.
8
Cross talk on therapeutic strategies: natriuretic peptides and inhibiting neprilysin in hypertension management.治疗策略中的相互作用:利钠肽与抑制中性肽链内切酶在高血压管理中的应用
Hypertens Res. 2025 Jan;48(1):284-300. doi: 10.1038/s41440-024-01989-w. Epub 2024 Nov 14.
9
Blunted increase in plasma BNP during acute coronary syndrome attacks in obese patients.肥胖患者急性冠脉综合征发作期间血浆脑钠肽升高不明显。
Int J Cardiol Heart Vasc. 2024 Sep 13;54:101508. doi: 10.1016/j.ijcha.2024.101508. eCollection 2024 Oct.
10
Recent Advances in Whiskers: Properties and Clinical Applications in Dentistry.近期胡须研究进展:特性及在牙科中的临床应用
Int J Nanomedicine. 2024 Jul 12;19:7071-7097. doi: 10.2147/IJN.S471546. eCollection 2024.